Literature DB >> 25181981

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 9 International classification of functioning, disability and health (ICF)].

U Kiltz1, W Mau, U Repschläger, E Böhle, J Braun.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25181981     DOI： 10.1007/s00393-014-1434-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  26 in total

1.  Which aspects of functioning are relevant for patients with ankylosing spondylitis: results of focus group interviews.

Authors:  Annelies Boonen; Monique van Berkel; Alarcos Cieza; Gerold Stucki; Désirée van der Heijde
Journal:  J Rheumatol       Date:  2009-10-15       Impact factor: 4.666

2.  Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health.

Authors:  Irene van Echteld; Alarcos Cieza; Annelies Boonen; Gerold Stucki; Jane Zochling; Jürgen Braun; Désirée van der Heijde
Journal:  J Rheumatol       Date:  2006-10-15       Impact factor: 4.666

3.  Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

Authors:  A Zink; J Braun; J Listing; J Wollenhaupt
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

4.  Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; A Spoorenberg; H Schouten; M Rutten-van Mölken; F Guillemin; M Dougados; H Mielants; K de Vlam; H van der Tempel; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

5.  Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis.

Authors:  Walter P Maksymowych; Katherine L Gooch; Robert L Wong; Hartmut Kupper; Désirée van der Heijde
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

6.  Impact of ankylosing spondylitis on work and family life: comparisons with the US population.

Authors:  Michael M Ward; John D Reveille; Thomas J Learch; John C Davis; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2008-04-15

7.  ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health.

Authors:  A Boonen; J Braun; I E van der Horst Bruinsma; F Huang; W Maksymowych; N Kostanjsek; A Cieza; G Stucki; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

8.  Role of contextual factors in health-related quality of life in ankylosing spondylitis.

Authors:  V S Gordeev; W P Maksymowych; S M A A Evers; A Ament; L Schachna; A Boonen
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

9.  Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.

Authors:  Annelies Boonen; Vaishali Patel; Shana Traina; Chiun-Fang Chiou; Andreas Maetzel; Wayne Tsuji
Journal:  J Rheumatol       Date:  2008-02-15       Impact factor: 4.666

10.  Work disability in ankylosing spondylitis: differences among working and work-disabled patients.

Authors:  Engin Cakar; Mehmet Ali Taskaynatan; Umit Dincer; Mehmet Zeki Kiralp; Oguz Durmus; Ahmet Ozgül
Journal:  Clin Rheumatol       Date:  2009-08-16       Impact factor: 2.980
View more
  2 in total

Review 1.  [Evidence-based recommendations on diagnostics and therapy of axial spondyloarthritis : S3 guidelines of the German Society of Rheumatology (DGRh) in cooperation with the Association of the Scientific Medical Societies in Germany (AWMF)].

Authors:  U Kiltz; M Rudwaleit; J Sieper; J Braun
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

2.  [Treat to participation : Position paper of the German Society for Rheumatology on sustained improvement of functional health of patients with rheumatic and musculoskeletal diseases].

Authors:  W Mau; W Beyer; I Ehlebracht-König; J-M Engel; E Genth; U Lange
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.